dpp4i and glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Renoprotective Effects of DPP-4 Inhibitors
Description
At the highest dose, 57 percent of participants lost at least 20 percent of their body weight results that rival surgical outcomes
Nausea can become a cycle: low appetite leads to low intake, low intake leads to weakness or queasiness, and then food feels even harder to tolerate
10.1038/s41574-022-00783-3 31 HavranekB.LohR.TorreB.RedfieldR.Halegoua-DemarzioD
*Disclaimer: Major Players sorted in no particular order Recent Industry Developments December 2025: WHO recommended GLP-1 receptor agonists as part of comprehensive adult-obesity care, citing cardio-metabolic benefits
